Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback